Paraffin Oil for Preventing Tourniquet-Related Skin Lesions in Upper Extremity Surgery (NCT07523958) | Clinical Trial Compass
RecruitingNot Applicable
Paraffin Oil for Preventing Tourniquet-Related Skin Lesions in Upper Extremity Surgery
Turkey (Türkiye)90 participantsStarted 2026-01-12
Plain-language summary
This randomized controlled trial aims to evaluate the effectiveness of topical paraffin oil application in preventing tourniquet-related skin lesions in patients undergoing upper extremity surgery. Pneumatic tourniquets are commonly used to provide a bloodless surgical field; however, they may cause skin complications such as erythema, edema, abrasions, blisters, and burns.
In this study, adult patients undergoing elective upper extremity surgery will be randomly assigned to either an intervention group receiving topical paraffin oil application in addition to routine protective dressing or a control group receiving routine care only. Skin integrity will be assessed immediately after tourniquet removal and at 30 and 60 minutes postoperatively using standardized skin assessment criteria.
The findings of this study are expected to contribute to the development of effective, simple, and cost-efficient strategies to prevent tourniquet-related skin complications and improve patient safety and postoperative comfort.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
IInclusion Criteria:
* Age ≥18 years
* Patients scheduled for elective upper extremity surgery requiring pneumatic tourniquet application
* ASA physical status I-III
* Body mass index (BMI) \<30 kg/m²
* Ability to provide informed consent
* Willingness to participate in the study
Exclusion Criteria:
* Age \<18 years
* Known dermatological disease or existing skin lesion at the tourniquet application site
* Allergy or sensitivity to paraffin oil or related substances
* Severe systemic disease (ASA IV or higher)
* Obesity (BMI ≥30 kg/m²)
* Emergency surgery
* Patients transferred to intensive care postoperatively
* Development of major postoperative complications (e.g., hematoma, seroma, nerve injury, significant bleeding)
* Inability to communicate or comply with study procedures
* Withdrawal from the study at any time
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Incidence of Tourniquet-Related Skin Injury
Timeframe: At 0, 30, and 60 minutes after tourniquet removal